CSS
HRMY icon

Cubist Systematic Strategies’s Harmony Biosciences HRMY Stock Holding History

Cubist Systematic Strategies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,172
Closed -$37K – 3235
2025
Q2 		$37K Buy
+1,172
New +$37.7K ﹤0.01% 2802
2024
Q2 		– Sell
-63,269
Closed -$2.12M – 3429
2024
Q1 		$2.12M Sell
63,269
-38,238
-38% -$1.23M 0.01% 1600
2023
Q4 		$3.28M Buy
+101,507
New +$2.83M 0.02% 1130
2023
Q3 		– Sell
-85,633
Closed -$3.01M – 3592
2023
Q2 		$3.01M Buy
85,633
+39,862
+87% +$1.38M 0.02% 1171
2023
Q1 		$1.49M Sell
45,771
-90,838
-66% -$4.14M 0.01% 1868
2022
Q4 		$7.53M Buy
136,609
+52,223
+62% +$2.87M 0.04% 682
2022
Q3 		$3.74M Buy
84,386
+60,069
+247% +$2.93M 0.02% 1361
2022
Q2 		$1.19M Sell
24,317
-70,470
-74% -$3.17M 0.01% 2337
2022
Q1 		$4.61M Buy
94,787
+51,787
+120% +$2.11M 0.04% 792
2021
Q4 		$1.83M Sell
43,000
-11,633
-21% -$464K 0.02% 1450
2021
Q3 		$2.09M Buy
54,633
+34,947
+178% +$1.13M 0.03% 980
2021
Q2 		$556K Buy
+19,686
New +$591K 0.01% 1939

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $86.2B AUM 12.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cubist Systematic Strategies's HRMY Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Harmony Biosciences (HRMY) in Q3 2025, closing a stake of 1,172 shares — an estimated $37K sold.

Cubist Systematic Strategies first reported a position in HRMY in Q2 2021 and held it in 12 quarters. The position peaked at $7.53M in Q4 2022. 296 funds tracked by Wall St. Rank hold HRMY as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Harmony Biosciences position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,172 Harmony Biosciences shares in Q3 2025, an estimated $37K.
  • Cubist Systematic Strategies first reported a position in Harmony Biosciences in Q2 2021 and held it in 12 quarters.
  • Cubist Systematic Strategies's Harmony Biosciences position peaked at $7.53M in Q4 2022.
  • 296 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.